Betulinic acid exerts potent antitumor effects on paclitaxel-resistant human lung carcinoma cells (H460) via G2/M phase cell cycle arrest and induction of mitochondrial apoptosis

por Zhan, Xiao-Kai, Li, Jun-Ling, Zhang, Sen, Xing, Pu-Yuan, Xia, Meng-Fan
Publicado 2018

A real‐world study of dacomitinib in later‐line settings for advanced non‐small cell lung cancer patients harboring EGFR mutations

por Li, Hong‐Shuai, Zhang, Jin‐Yao, Yan, Xiang, Xu, Hai‐Yan, Hao, Xue‐Zhi, Xing, Pu‐Yuan, Wang, Yan
Publicado 2022

Efficacy and safety of concomitant immunotherapy and denosumab in patients with advanced non-small cell lung cancer carrying bone metastases: A retrospective chart review

por Li, Hong-Shuai, Lei, Si-Yu, Li, Jun-Ling, Xing, Pu-Yuan, Hao, Xue-Zhi, Xu, Fei, Xu, Hai-Yan, Wang, Yan
Publicado 2022

Influence of PD‐L1 expression on the efficacy of EGFR‐TKIs in EGFR ‐mutant non‐small cell lung cancer

por Lei, Si‐Yu, Xu, Hai‐Yan, Li, Hong‐Shuai, Yang, Ya‐Ning, Xu, Fei, Li, Jun‐Ling, Wang, Zhi‐Jie, Xing, Pu‐Yuan, Hao, Xue‐Zhi, Wang, Yan
Publicado 2023

Changes and Influential Factors of Chemotherapy Usage for Non-Small Cell Lung Cancer Patients in China: A Multicenter 10-Year (2005–2014) Retrospective Study

por Xing, Pu-Yuan, Wang, Shou-Zheng, Shi, Ju-Fang, Wang, Le, Hui, Zhou-Guang, Ren, Jian-Song, Liu, Shang-Mei, Qiao, You-Lin, Dai, Min, Li, Jun-Ling
Publicado 2020

Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis

por Zhu, Hao‐Hua, Liu, Yu‐Tao, Feng, Yu, Zhang, Li‐Na, Zhang, Tong‐Mei, Dong, Gui‐Lan, Xing, Pu‐Yuan, Wang, Hong‐Yu, Shi, Yuan‐Kai, Hu, Xing‐Sheng
Publicado 2021

Depth of Response was Associated with Progression-Free Survival in Patients with Advanced Non-small Cell Lung Cancer treated with EGFR-TKI

por Liu, Yu-Tao, Zhang, Kai, Li, Cheng-Cheng, Hu, Xing-Sheng, Jiang, Jun, Hao, Xue-Zhi, Wang, Yan, Li, Jun-Ling, Xing, Pu-Yuan, Yang, Sheng, Zhang, Xin, Wang, Guo-Qiang, Cai, Shang-Li, Shi, Yuan-Kai
Publicado 2019

Afatinib and Dacomitinib Efficacy, Safety, Progression Patterns, and Resistance Mechanisms in Patients with Non-Small Cell Lung Cancer Carrying Uncommon EGFR Mutations: A Comparati...

por Li, Hong-Shuai, Wang, Shou-Zheng, Xu, Hai-Yan, Yan, Xiang, Zhang, Jin-Yao, Lei, Si-Yu, Li, Teng, Hao, Xue-Zhi, Zhang, Tao, Yang, Guang-Jian, Zhou, Li-Qiang, Liu, Peng, Wang, Yu-Ying, Hu, Xing-Sheng, Xing, Pu-Yuan, Wang, Yan
Publicado 2022

What are the clinical symptoms and physical signs for non‐small cell lung cancer before diagnosis is made? A nation‐wide multicenter 10‐year retrospective study in China

por Xing, Pu‐Yuan, Zhu, Yi‐Xiang, Wang, Le, Hui, Zhou‐Guang, Liu, Shang‐Mei, Ren, Jian‐Song, Zhang, Ye, Song, Yan, Liu, Cheng‐Cheng, Huang, Yun‐Chao, Liao, Xian‐Zhen, Xing, Xiao‐Jing, Wang, De‐Bin, Yang, Li, Du, Ling‐Bin, Liu, Yu‐Qin, Zhang, Yong‐Zhen, Liu, Yun‐Yong, Wei, Dong‐Hua, Zhang, Kai, Shi, Ju‐Fang, Qiao, You‐Lin, Chen, Wan‐Qing, Li, Jun‐Ling, Dai, Min
Publicado 2019